Lihit Lab.,Inc. (7975.T)
JPY 1137.0
(0.62%)
JPY 1137.0
(0.62%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 663.33 Million | -745.69 Million | 720.73 Million | 726.37 Million | 858.69 Million |
| Net Income | -119.3 Million | -32.21 Million | 406.94 Million | 502.72 Million | 337.39 Million |
| Depreciation & Amortization | 289.13 Million | 290.19 Million | 313.62 Million | 330.35 Million | 351.01 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 365.6 Million | -677.67 Million | 135.96 Million | 8.64 Million | 256.94 Million |
| Other non-cash items | 158.57 Million | -189.3 Million | -62.3 Million | 15.85 Million | 508.4 Million |
| Investing Cash Flow | -726.91 Million | -112.96 Million | -127.15 Million | -129.18 Million | -332.26 Million |
| Investments in PPE | -859.96 Million | -79.93 Million | -112.09 Million | -111.78 Million | -306.25 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -1.96 Million | -905 Thousand | -795 Thousand | -768 Thousand | -753 Thousand |
| Sales/Maturities of investments | 170.16 Million | - | - | - | - |
| Other Investing Activities | -35.14 Million | -32.12 Million | -14.26 Million | -16.62 Million | -25.25 Million |
| Financing Cash Flow | 220.13 Million | -339.34 Million | -139.15 Million | -475.31 Million | -118.64 Million |
| Debt repayment | -306.5 Million | -253 Million | -53 Million | -389 Million | -17 Million |
| Dividends payments | -84.69 Million | -84.88 Million | -84.58 Million | -84.81 Million | -101.34 Million |
| Common Stock Repurchased | -293 Thousand | -77 Thousand | -188 Thousand | -124 Thousand | -296 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1.38 Million | -1.38 Million | -1.38 Million | -1.38 Million | - |
| Accounts receivables | 28 Million | -130 Million | 234 Million | 140 Million | -28.36 Million |
| Accounts payables | 4.29 Million | -300.7 Million | -43.63 Million | -81.91 Million | -130.14 Million |
| Inventory | 322.95 Million | -250.21 Million | -67.5 Million | 2.37 Million | 265.48 Million |
| Other working capital | 196 Million | -163 Million | -31 Million | -22 Million | 149.96 Million |
| Cash at beginning of period | 1.07 Billion | 2.25 Billion | 1.79 Billion | 1.67 Billion | 1.27 Billion |
| Cash at end of period | 1.24 Billion | 1.07 Billion | 2.25 Billion | 1.79 Billion | 1.67 Billion |
| Capital Expenditure | -859.96 Million | -79.93 Million | -112.09 Million | -111.78 Million | -306.25 Million |
| Effect of forex changes on cash | 8.76 Million | 15.49 Million | 8.04 Million | -3.65 Million | - |
| Net cash flow / Change in cash | 165.32 Million | -1.18 Billion | 462.46 Million | 118.21 Million | 407.32 Million |
| Free Cash Flow | -196.63 Million | -825.63 Million | 608.64 Million | 614.58 Million | 552.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16 Million | 59 Million | -26 Million | -119.3 Million | -64 Million | 4 Million |
| Depreciation & Amortization | - | - | - | 289.13 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 365.6 Million | - | - |
| Other non-cash items | 16 Million | -59 Million | 26 Million | 158.57 Million | 64 Million | -4 Million |
| Investing Cash Flow | - | - | - | -726.91 Million | - | - |
| Investments in PPE | - | - | - | -859.96 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -1.96 Million | - | - |
| Sales/Maturities of investments | - | - | - | 170.16 Million | - | - |
| Other Investing Activities | - | - | - | -35.14 Million | - | - |
| Financing Cash Flow | - | - | - | 220.13 Million | - | - |
| Debt repayment | - | - | - | -306.5 Million | - | - |
| Dividends payments | - | - | - | -84.69 Million | - | - |
| Common Stock Repurchased | - | - | - | -293 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -1.38 Million | - | - |
| Accounts receivables | - | - | - | 28 Million | - | - |
| Accounts payables | - | - | - | 4.29 Million | - | - |
| Inventory | - | - | - | 322.95 Million | - | - |
| Other working capital | - | - | - | 196 Million | - | - |
| Cash at beginning of period | - | - | - | 1.07 Billion | - | - |
| Cash at end of period | - | - | - | 1.24 Billion | - | - |
| Capital Expenditure | - | - | - | -859.96 Million | - | - |
| Effect of forex changes on cash | - | - | - | 8.76 Million | - | - |
| Net cash flow / Change in cash | - | - | - | 165.32 Million | - | - |
| Free Cash Flow | - | - | - | -196.63 Million | - | - |
3275
ADEN
8541
MS-PP
4425
2471